118 related articles for article (PubMed ID: 12873784)
1. Thrombin-antithrombin complex and alpha2-plasmin inhibitor-plasmin complex levels after cesarean section in normal pregnancies and pre-eclampsia.
Hayashi M; Hamada Y; Ohkura T
Int J Gynaecol Obstet; 2003 Aug; 82(2):213-6. PubMed ID: 12873784
[No Abstract] [Full Text] [Related]
2. The influence of labor on thrombotic and fibrinolytic systems.
Yoshimura T; Ito M; Nakamura T; Okamura H
Eur J Obstet Gynecol Reprod Biol; 1992 May; 44(3):195-9. PubMed ID: 1535054
[TBL] [Abstract][Full Text] [Related]
3. Thrombin-antithrombin complex and alpha-plasmin inhibitor-plasmin complex levels in singleton and twin pregnancies.
Hayashi M; Fukasawa I; Inaba N
Int J Clin Pract; 2006 Oct; 60(10):1244-9. PubMed ID: 16669831
[TBL] [Abstract][Full Text] [Related]
4. [Plasma levels of antithrombin III, thrombin-antithrombin III complex, alpha 2 plasmin inhibitor and plasmin alpha 2 plasmin inhibitor complex in normal and sick newborn infants].
Shiiki M; Ariyoshi N; Nakamura T; Shirahata A
Rinsho Ketsueki; 1991 Jul; 32(7):758-65. PubMed ID: 1833569
[TBL] [Abstract][Full Text] [Related]
5. [Increased complexes between protease and protease inhibitor in the plasma from patients with neoplasm].
Okadome T; Maruyama I; Shinmyouzu K; Jounosono M; Osame M
Rinsho Ketsueki; 1988 Dec; 29(12):2283-6. PubMed ID: 2977624
[No Abstract] [Full Text] [Related]
6. Activation of blood coagulation and fibrinolysis in diabetes mellitus: evaluation by plasma levels of thrombin-antithrombin III complex and plasmin-alpha 2-plasmin inhibitor complex.
Takahashi H; Tsuda A; Tatewaki W; Wada K; Niwano H; Shibata A
Thromb Res; 1989 Sep; 55(6):727-35. PubMed ID: 2528845
[TBL] [Abstract][Full Text] [Related]
7. Coagulation and fibrinolysis activation markers in prostatic carcinoma patients.
Geenen RW; Delaere KP; van Wersch JW
Eur J Clin Chem Clin Biochem; 1997 Feb; 35(2):69-72. PubMed ID: 9056745
[TBL] [Abstract][Full Text] [Related]
8. High plasma level of plasmin-alpha 2-plasmin inhibitor complex is predictor of poor prognosis in patients with lung cancer.
Taguchi O; Gabazza EC; Yoshida M; Yamakami T; Kobayashi H; Shima T
Clin Chim Acta; 1996 Jan; 244(1):69-81. PubMed ID: 8919202
[TBL] [Abstract][Full Text] [Related]
9. Significance of elevated thrombin-antithrombin III complex and plasmin-alpha 2-plasmin inhibitor complex in the acute stage of nontraumatic subarachnoid hemorrhage.
Itoyama Y; Fujioka S; Takaki S; Morioka M; Hide T; Ushio Y
Neurosurgery; 1994 Dec; 35(6):1055-60. PubMed ID: 7533897
[TBL] [Abstract][Full Text] [Related]
10. Experimental haemorrhage and blood component transfusion in humans: no change in plasma concentration of thrombin-antithrombin complex and plasmin-antiplasmin complex.
Henriksson AE; Nilsson TK; Jansson U; Bergqvist D
Thromb Res; 1996 Jun; 82(5):409-15. PubMed ID: 8771701
[TBL] [Abstract][Full Text] [Related]
11. TAT and PAP in hemodialysis patients: two cats in a bag?
Haznedaroğlu IC; Erdem Y; Dündar S; Cağlar S; Kirazh S
Thromb Res; 1995 Dec; 80(5):447-9. PubMed ID: 8588208
[No Abstract] [Full Text] [Related]
12. Hemostasis in the uteroplacental and peripheral circulations in normotensive and pre-eclamptic pregnancies.
Higgins JR; Walshe JJ; Darling MR; Norris L; Bonnar J
Am J Obstet Gynecol; 1998 Aug; 179(2):520-6. PubMed ID: 9731863
[TBL] [Abstract][Full Text] [Related]
13. Thrombin generation in patients with thrombotic thrombocytopenic purpura.
Takahashi H; Tatewaki W; Wada K; Shibata A
Am J Hematol; 1989 Dec; 32(4):255-7. PubMed ID: 2479264
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of the ratio between the alpha 2 plasmin inhibitor-plasmin complex and the thrombin-antithrombin complex in advanced non-small cell lung cancer.
Masago K; Fujita S; Mio T; Togashi Y; Kim YH; Hatachi Y; Fukuhara A; Irisa K; Sakamori Y; Mishima M
Med Oncol; 2011 Mar; 28(1):351-6. PubMed ID: 20300980
[TBL] [Abstract][Full Text] [Related]
15. [Antithrombin III and alpha 2-antiplasmin in blood of patients operated on for benign prostatic hyperplasia].
Zietek Z; Iwan-Zietek I; Kotschy M; Tyloch F
Pol Tyg Lek; 1996 Feb; 51(6-9):75-6. PubMed ID: 8756735
[TBL] [Abstract][Full Text] [Related]
16. [Changes in coagulation and fibrinolysis cascades upon extracorporeal circulation].
Kanamori N; Koiwa F; Uda S
Nihon Rinsho; 1991 Dec; 49 Suppl():81-6. PubMed ID: 1839690
[No Abstract] [Full Text] [Related]
17. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
[TBL] [Abstract][Full Text] [Related]
18. Haemostatic changes; plasma levels of alpha2-antiplasmin-plasmin complex and thrombin-antithrombin III complex in female breast cancer.
Ozyilkan O; Baltali E; Ozdemir O; Tekuzman G; Kirazli S; Firat D
Tumori; 1998; 84(3):364-7. PubMed ID: 9678618
[TBL] [Abstract][Full Text] [Related]
19. Evaluating systemic lupus erythematosus disease activity using molecular markers of hemostasis.
Inoh M; Tokuda M; Kiuchi H; Kurata N; Takahara J
Arthritis Rheum; 1996 Feb; 39(2):287-91. PubMed ID: 8849381
[TBL] [Abstract][Full Text] [Related]
20. [Studies on coagulation-fibrinolytic system in diabetic nephropathy--with reference to plasma TAT and alpha 2PIC].
Watanabe S; Ogihara T; Iyori S; Kaneshige H; Nomoto Y; Sakai H
Nihon Jinzo Gakkai Shi; 1990 Sep; 32(9):995-9. PubMed ID: 2148199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
